Front (Diclofenacpi)
Diclofenac Sodium 1.5%
Product Images NDC 50436-2225
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium 1.5% (NDC 50436-2225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Back (Diclofenacpiback)
A (Figurea)
B (Figureb)
C (Figurec)
Formula (Formula)
Label Image (Lbl504362225)
This is a label for a medication containing diclofenac sodium. The concentration of the active ingredient is 1.5% / 150 MU Mg per L. The medication is made by SOLA Pharmaceuticals in Baton Rouge, LA and dispensed by MEGNOC. It comes with a patient guide and should be kept out of reach of children. The recommended storage temperature is not specified. There are multiple NDC and DRUG codes listed on the label.*
Table (Table1)
This is a list of adverse reactions that may occur when using Diclofenac Sodium in the form of a topical solution. The table shows the number of patients in a treatment group (N=911) that experienced each reaction, with percentages for both the treatment and placebo groups. Some common reactions include dry skin at the application site, contact dermatitis, dyspepsia, abdominal pain, and pruritus. However, other reactions such as accidental injury, halitosis, and sinusitis were less commonly reported.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
